In a move poised to reshape the global metabolic API landscape, respected Viking pharmaceutical company Rune Pharmaceuticals has announced a groundbreaking strategic alliance with a prominent American Tirzepatide firm. This partnership will see both entities collaborate on enhancing the supply chain for metabolic APIs, ensuring uninterrupted access